Clebre S.A.

Manufacture of other medical instruments and supplies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-11-19
Share capital
313,376.00 PLN
Activity description

Clebre provides personalized treatment for sleep and breathing disorders. The company offers diagnosis, therapy, and monitoring where the patient sleeps at home, and also supports people who have not adapted to CPAP.

Registered address
ul. Artyleryjska 3K, 10-165 Olsztyn, Poland
Website
Email
Phone
Social media
Electronic delivery address
AE:PL-87744-34712-IWFAB-19

Financials

Revenue history (in k)

From the notes

Loans and borrowings$17,039

Filing timeliness

2 of 5 financial statements were filed late (the longest delay 179 days for 2023). All were audited by a statutory auditor.

  • 202526/06/2026
  • 202411/07/2025
  • 202310/01/2025
  • 202230/06/2023
  • 202127/09/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Other manufacturing552 / 700
Top 79%
Sector · Manufacturing21,671 / 24,603
Top 88%
City · Olsztyn1,489 / 1,893
Top 79%
Voivodeship · Warmińsko-Mazurskie4,816 / 5,936
Top 81%
Country · Poland239,396 / 297,566
Top 80%

Results vs industry

Revenue
This companyUSD 29.82kMedianUSD 900.38kAverageUSD 7.84m
Net profit
This companyUSD -244.28kMedianUSD 78.86kAverageUSD 602.99k
Operating costs
This companyUSD 255.08kMedianUSD 682.06kAverageUSD 6.88m
Assets
This companyUSD 556.56kMedianUSD 920.53kAverageUSD 6.59m

Offer

Websites

The site is available in: Polish and English.

  • clebre.comStrona główna – Clebre – spersonalizowane leczenie zaburzeń snu i oddychania
    WooCommerceWordPress 3.7ElementorStripeLinkedIn AdsGoogle AnalyticsGoogle Tag ManagerRank MathApache

Authorized Representatives

Maciej Andrzej Migacz age 44 – President of the Management Board
Wojciech Sebastian Kukwa age 50 – Vice President of the Management Board

Manner of representation

Each member of the management board acting independently is authorised to represent the company and to submit all declarations on its behalf.

Supervisory board

Andrzej Tadeusz Janiszowski age 47 – Supervisory Board Member
Marcel Cezary Młyńczak age 36 – Supervisory Board Member
Jacek Deneka age 52 – Supervisory Board Member
Piotr Stanisław Woźny age 55 – Supervisory Board Member

Bank accounts

Registered as a VAT taxpayer on 2016-02-15.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid for research and development projects: industrial research
$663.4K
Aid for research and development projects: experimental development
$185.4K

Competitors

Name
Spiroclinic sp. z o.o.
G3 Medical Holding S.A.
Neurodiagnostyka sp. z o.o.
Magna Superstes sp. z o.o.
CM7 sp. z o.o.
Sentre sp. z o.o.
Biomed Neurotechnologie sp. z o.o.
Health & Security sp. z o.o.
Medapp Clinics sp. z o.o.
Centrum Terapii Alma Bełchatów sp. z o.o.

Change history

DateEvent
2026-06-26Share capital increase
2021-11-19Entered in the register

FAQ

Last updated: 2026-07-10